Evogene

(NASDAQ) EVGN

Current Price$0.43

Market Cap$4.71M

Since IPO (2008)-97%

5 Year-99%

1 Year-70%

1 Month-45%

Evogene Financials at a Glance

Market Cap

$4.71M

Revenue (TTM)

$1.84M

Net Income (TTM)

-$11.77M

EPS (TTM)

-$1.38

P/E Ratio

-0.28

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$0.43

Volume

278,420.392

Open

$0.39

Price

$0.43

Volume

278,420.392

Open

$0.39

Previous Close

$0.43

Daily Range

$0.39 - $0.44

52-Week Range

$0.37 - $1.50

Estimated Earnings Date

Aug 26, 2026

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$0.43

Volume

278,420.392

Open

$0.39

Previous Close

$0.43

Daily Range

$0.39 - $0.44

52-Week Range

$0.37 - $1.50

Estimated Earnings Date

Aug 26, 2026

EVGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evogene

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ofer Haviv, CPA

Website

www.evogene.com

Headquarters

Rehovot, 7414002, IL

EVGN Financials

Key Financial Metrics (TTM)

Gross Margin

30.93%

Operating Margin

-757.22%

Net Income Margin

-639.39%

Return on Equity

937.72%

Return on Capital

-663.23%

Return on Assets

-65.36%

Earnings Yield

-3.57%

Dividend Yield

0.00%

Payout Ratio

-1.65%

Stock Overview

Market Cap

$4.71M

Shares Outstanding

12.10M

Volume

278.42K

Avg. Volume

1.08M

Financials (TTM)

Gross Profit

-$863.00K

Operating Income

-$14.16M

EBITDA

-$12.88M

Operating Cash Flow

-$11.73M

Capital Expenditure

-$21.29K

Free Cash Flow

-$11.75M

Cash & ST Invst.

$13.05M

Total Debt

$2.03M

Evogene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$334.00K

-86.3%

Gross Profit

$204.00K

-75.4%

Gross Margin

61.08%

N/A

Market Cap

$4.71M

N/A

Market Cap/Employee

$40.23K

N/A

Employees

117

N/A

Net Income

-$5.87M

-126.9%

EBITDA

-$1.82M

+6.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$13.05M

+32.5%

Total Debt

$2.03M

-84.3%

Accounts Receivable

$1.70M

-48.3%

Inventory

$175.00K

-91.9%

Long Term Debt

$1.38M

-28.4%

Short Term Debt

$654.00K

-94.1%

Return on Assets

-65.36%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

-$2.96M

+44.3%

Operating Cash Flow

-$2.95M

+43.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMNNImunon, Inc.

IMNNImunon, Inc.$1.80+0.56%

DWTXDogwood Therapeutics, Inc.

DWTXDogwood Therapeutics, Inc.$1.78+7.88%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$3.91-8.66%

CLRBCellectar Biosciences, Inc.

CLRBCellectar Biosciences, Inc.$2.60+3.17%

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$1.03+0.98%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+11.03%

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$13.85-22.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.22+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92+0.00%

NOKNokia

NOKNokia$13.03+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SOFISoFi Technologies

SOFISoFi Technologies$18.19+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

Questions About EVGN

What is the current price of Evogene?

Evogene is trading at $0.43 per share.

What is the 52-week range for Evogene?

Over the past 52 weeks, Evogene has traded between $0.37 and $1.50.

How much debt does Evogene have?

As of the most recent reporting period, Evogene reported total debt of $2.03M.

How much cash does Evogene have on hand?

Evogene reported $8.54M in cash and cash equivalents in its most recent financial results.

What is Evogene’s dividend yield?

Evogene does not currently have a dividend yield.

Evogene

Evogene Financials at a Glance

EVGN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Evogene

EVGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Evogene Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EVGN

What is the current price of Evogene?

What is the 52-week range for Evogene?

How much debt does Evogene have?

How much cash does Evogene have on hand?

What is Evogene’s dividend yield?

Premium Investing Services